Erasca Quarterly Balance Sheet
NASDAQ: ERASHealthcareBiotechnologyUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Erasca financial position
As of Jun 30, 2026, Erasca reported total assets of $435.1 million, down 2.3% from a year earlier against total liabilities of $73.2 million. Shareholders' equity stood at $361.9 million, or 83.2% of assets. The company held $42.5 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 8.29, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Erasca balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 42.54M | 47.26M | 73.81M | 70.23M | 66.14M | 70.48M | 67.74M | 68.89M | 172.80M | 172.80M | 93.08M | 112.86M |
| Short-Term Investments | 226.20M | 196.53M | 202.27M | 218.17M | 234.52M | 234.10M | 230.57M | 250.03M | 235.61M | 220.96M | 219.28M | 183.81M |
| Total Current Assets | 278.44M | 253.78M | 286.24M | 299.93M | 310.66M | 314.62M | 308.79M | 330.17M | 418.00M | 306.62M | 320.68M | 305.97M |
| Property, Plant & Equipment | 11.92M | 12.61M | 13.30M | 14.04M | 14.82M | 15.59M | 16.32M | 17.15M | 17.99M | 21.36M | 22.33M | 23.23M |
| Long-Term Investments | 115.53M | 164.72M | 65.72M | 73.98M | 86.09M | 106.49M | 142.16M | 144.39M | 51.84M | — | 9.64M | 46.89M |
| Total Assets | 435.05M | 461.23M | 396.15M | 420.40M | 445.39M | 471.24M | 502.53M | 528.90M | 525.74M | 370.02M | 395.30M | 419.41M |
| Accounts Payable | 2.02M | 2.16M | 981.00K | 3.03M | 1.66M | 2.26M | 468.00K | 2.40M | 2.14M | 2.63M | 2.00M | 3.70M |
| Total Current Liabilities | 33.57M | 26.66M | 28.51M | 28.71M | 28.15M | 25.47M | 31.39M | 30.02M | 24.89M | 30.24M | 26.16M | 26.73M |
| Total Liabilities | 73.19M | 67.71M | 70.98M | 72.52M | 73.13M | 71.74M | 79.03M | 78.85M | 74.66M | 81.61M | 78.61M | 80.43M |
| Shareholders' Equity | 361.87M | 393.53M | 325.17M | 347.89M | 372.26M | 399.50M | 423.50M | 450.04M | 451.09M | 288.41M | 316.69M | 338.98M |
| Retained Earnings | -1.12B | -1.08B | -892.21M | -863.12M | -832.50M | -798.63M | -767.66M | -735.43M | -704.23M | -641.03M | -606.01M | -576.31M |
| Net Cash (Debt) | 268.74M | 243.79M | 276.07M | 288.40M | 300.66M | 304.58M | 298.31M | 318.91M | 408.41M | 393.76M | 312.35M | 296.67M |
| Shares Outstanding | 312.56M | 310.81M | 284.16M | 283.71M | 283.65M | 283.27M | 283.22M | 282.69M | 273.04M | 151.25M | 151.09M | 150.54M |
This table shows 12 quarterly periods of Erasca's balance sheet, from Q2 2026 back to Q3 2023, across 13 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow ERAS's reporting calendar. What is a balance sheet?